Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the postpartum depression market?
The postpartum depression market has experienced exponential growth, with forecasts indicating a rise from $12.15 billion in 2024 to $16.09 billion in 2025, at a CAGR of 32.4%. This growth has been fueled by increasing awareness of maternal mental health, advancements in research, public health initiatives, and enhanced screening programs.
What will be the postpartum depression market size in the future?
The postpartum depression market is set for exponential growth, soaring to $49.4 billion by 2029 with a CAGR of 32.4%. Growth factors include increasing telehealth services, pharmacological advancements, maternal mental health policies, and workforce expansion in mental healthcare. Major trends include integrated care models, peer support initiatives, perinatal mental health applications, and improved screening tools.
Get your postpartum depression market report here!
https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report
What main drivers are fueling expansion in the postpartum depression market?
Anticipated growth in the postpartum depression market is thought to be fueled by a surge in postpartum depression incidents. Postpartum depression represents intense post-birth concern, often supplemented by physical symptoms. Postnatal depression is commonly coincident with postpartum anxiety and can potentially start at any point during the first year post-birth. Both medication and psychotherapy, alternatively known as talk therapy or professional mental health counseling, or a combination of both are typically applied to treat postpartum depression, contributing to market growth. For instance, a February 2022 study involving 1.1 million mothers conducted by the US-based University of Virginia School of Medicine (UVA SoM) found the Risk of postpartum depression is greatest among new mothers, those under 25, and mothers of twins. Postpartum depression symptoms were reported by 10% of women aged 18-24, which was the highest across all age groups. Twin mothers presented slightly higher rates of postpartum depression at 11.3% as opposed to 8.3% for single-child mothers. Hence, the rising cases of postpartum depression are bolstering the postpartum depression market.
Postpartum Depression Market Propellant: Surge in Childbirth Numbers Fuels Growth
What key areas define the segmentation of the global postpartum depression market?
The postpartum depression market covered in this report is segmented –
1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types
2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments
3) By Route of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings
2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks
3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors
4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms
5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety
6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings
7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp
Who are the dominant players expanding their reach in the postpartum depression market?
Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.
How are evolving market trends shaping postpartum depression Strategies?
In the postpartum depression market, companies strive to remain competitive by consistently innovating new products. The currently limited options for treatment necessitate the development of therapies that act more rapidly and novel modes of care delivery for postpartum depression. For example, Biogen Inc. and Sage Therapeutics Inc., both American companies, one a biotech and the other a biopharmaceutical, declared in February 2023 that the FDA has given its acceptance for an NDA for their experimental drug, zuranolone, to combat major depressive disorder (MDD) and postpartum depression (PPD). The experimental drug, zuranolone, is being trialed as an everyday, 14-day, fast-acting oral treatment for those struggling with MDD and PPD. Zuranolone, a neuroactive hormone, works as a positive modulator for GABA-A receptors, which represents an unprecedented mechanism of action. The expectation is that it will address depression swiftly by restoring the brain networks that regulate mood, arousal, behavior, and also cognition, that have experienced significant disruption.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13024
Which regions are emerging as leaders in the postpartum depression market?
North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Telepsychiatry Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report
Behavioral and Mental Health Software Global Market Report 2024
Residential Substance Abuse And Mental Health Facilities Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
